
- Volume 0 0
Probiotics Relieve Antibiotic-associated Diarrhea
Antibiotic-associated diarrhea occurs inup to 30% of patients who receive antibiotics,but it can be prevented with probiotics,according to research. JacekMrukowicz, Dr Med, and Hania Szajewska,Dr Med, systematically evaluated the effectivenessof Saccharomyces boulardii inpreventing antibiotic-associated diarrhea inchildren and adults. For the study, reportedin Alimentary Pharmacology & Therapeutics(September 2005), electronic databasesand references in review articleswere searched for studies relevant to antibiotic-associated diarrhea and S boulardii.
Of 16 potentially relevant clinical trialsidentified, 5 randomized, placebo-controlledtrials—with a total of 1076 participants—met the inclusion criteria for thissystematic review. Results of the metaanalysisrevealed that treatment with Sboulardii, compared with placebo, reducedthe risk for antibiotic-associated diarrheafrom 17.2% to 6.7% (relative risk, 0.43;95% confidence interval [CI], 0.23-0.78;random effect model). The number neededto treat to prevent one case of antibiotic-associated diarrhea was 10 (95% CI, 7-16). No adverse effects were reported.This analysis suggested that S boulardii ismoderately effective in preventing antibiotic-associated diarrhea in children andadults treated with antibiotics for any reason(mainly respiratory tract infections).
Articles in this issue
about 20 years ago
CAN YOU READ THESE Rxs?about 20 years ago
Bar Coding Thwarts Illegitimate Drug Useabout 20 years ago
Hypertension Counseling Requires a Multifactorial Approachabout 20 years ago
COMPOUNDING HOTLINEabout 20 years ago
Pharmacy Law: Duty to Warn Waived When Patient Refuses Counselingabout 20 years ago
EnterpriseRx Pharmacy Management Systemabout 20 years ago
Hospital Installs Automated Medication Cabinetsabout 20 years ago
"Smartphones" Help with Clinical Trial Informationabout 20 years ago
HIT Needs Medicare's LeadershipNewsletter
Stay informed on drug updates, treatment guidelines, and pharmacy practice trends—subscribe to Pharmacy Times for weekly clinical insights.












































































































































































































